2,2'-(9,9-Dioctyl-9H-fluorene-2,7-diyl)bis(1,3,2-dioxaborinane)

Catalog No. :
ACKFZM017
CAS No. :
317802-08-7
Molecular Formula :
C35H52B2O4
Molecular Weight :
558.42

IUPAC Name:2,2'-(9,9-dioctyl-9H-fluorene-2,7-diyl)bis(1,3,2-dioxaborinane)

2,2'-(9,9-Dioctyl-9H-fluorene-2,7-diyl)bis(1,3,2-dioxaborinane) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$137.00Login to see priceIn stockInquiry
25g98%$551.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2'-(9,9-Dioctyl-9H-fluorene-2,7-diyl)bis(1,3,2-dioxaborinane)
IUPAC Name2,2'-(9,9-dioctyl-9H-fluorene-2,7-diyl)bis(1,3,2-dioxaborinane)
MDL No.MFCD03701607
Molecular FormulaC35H52B2O4
Molecular Weight558.42
SMILESCCCCCCCCC1(CCCCCCCC)C2=C(C3=C1C=C(B4OCCCO4)C=C3)C=CC(B5OCCCO5)=C2
InChI KeyKAYXDWIILRESPY-UHFFFAOYSA-N
Synonym2,2'-(9,9-dioctyl-9h-fluorene-2,7-diyl)bis(1,3,2-dioxaborinane) | SCHEMBL793599 | 2-[7-(1,3,2-dioxaborinan-2-yl)-9,9-dioctyl-fluoren-2-yl]-1,3,2-dioxaborinane | 2-[7-(1,3,2-dioxaborinan-2-yl)-9,9-dioctylfluoren-2-yl]-1,3,2-dioxaborinane | 9,9-Dioctylfluor
CAS No.317802-08-7
PubChem CID4378560

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKFZM017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJZMP816 route compound structure diagram
    ACJZMP816258865-48-4 In Stock
  2. Then
  3. ACKFZM017 route product structure diagram
    ACKFZM017317802-08-7 In Stock
Inquiry

2. ACKFZM017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKFZM017 route product structure diagram
    ACKFZM017317802-08-7 In Stock
Inquiry

Comments (0)